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Abstract
Background: Cardiotoxicity is a documented complication of Crotalinae envenomation. Reported cardiac
complications following snake envenomation have included acute myocardial infarction, electrocardiogram
abnormalities and arrhythmias. Few reports exist describing arrhythmia induced by viper envenomation and to our
knowledge none describe arrhythmia induced by Crotalinae envenomation. This report concerns the first known
case of atrial fibrillation precipitated by rattlesnake bite.
Case presentation: A 73-year-old Caucasian man with a past medical history of hypertension, hyperlipidemia, type
1 diabetes mellitus, and a baseline first-degree atrioventricular block presented to the emergency department
following a rattlesnake bite to his left lower leg. He developed pain and swelling in his left leg two-hour post-
envenomation and subsequently received four vials of Crotalidae polyvalent immune fab (ovine). At three-hour
post-envenomation following transfer to the intensive care unit, an electrocardiogram revealed new-onset atrial
fibrillation. An amiodarone drip was started and the patient successfully converted to normal sinus rhythm
approximately six hours after he was found to be in atrial fibrillation. A transthoracic echocardiogram revealed mild
concentric left ventricular hypertrophy and an ejection fraction of 72%. He was discharged the following day with
no hematological abnormalities and a baseline first-degree atrioventricular block.
Conclusion: This is the first documented case of reversible atrial fibrillation precipitated by Crotalinae
envenomation. In patients with pertinent risk factors for developing atrial fibrillation, physicians should be aware of
the potential for this arrhythmia. Direct toxic effects of venom or structural and electrophysiological cardiovascular
abnormalities may predispose snakebite patients to arrhythmia, warranting extended and attentive cardiac
monitoring.
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Background
Endemic to Asia and the Americas, the Viperidae subfamily
of snakes known as Crotalinae is comprised of rattlesnakes,
cottonmouths, and copperheads in North America;
Bothrops in Central and South America; and the Asiatic pit
vipers [1, 2]. Clinical manifestations of Crotalinae envenom-
ation often include local tissue reaction with systemic
effects such as nausea, vomiting, diarrhea, diaphoresis, and
weakness. Severe cases are characterized by coagulopathy
with hemorrhagic manifestations, as well as renal failure
[3]. While the potential nephrotoxic, myotoxic, and neuro-
toxic effects of Viperidae family snake venom are well
documented, cardiotoxicity is infrequently described in the
literature. Reported cardiac complications following snake
envenomation have included acute myocardial infarction,
electrocardiogram (ECG) abnormalities, and arrhythmias
[4–16]. Few reports exist describing arrhythmia induced by
viper envenomation, and to our knowledge none describe
arrhythmia induced by Crotalinae envenomation. This
report concerns a case of atrial fibrillation (AF) precipitated
by rattlesnake bite.
Case presentation
A 73-year-old Caucasian man presented to the emergency
department following a rattlesnake bite to his left lower leg.
The envenomation occurred 30 min prior to his arrival by
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ambulance while he was retrieving a golf ball at a local golf
course. On presentation, the patient was alert, complained
of pain localized to the left lower extremity, and denied
having chest pain, palpitations or dyspnea. His past medical
history included hypertension, hyperlipidemia and type 1
diabetes mellitus. Current medications included lisinopril,
hydrochlorothiazide, atorvastatin, fluoxetine and insulin.
On examination, two puncture wounds and mild swelling
were noted anteriorly on the patient’s left lower leg.
An ECG taken approximately one hour after en-
venomation showed him to be in sinus rhythm with a
rate of 87 beats per minute. Additionally, a PR interval
of 220 ms was indicative of a baseline first-degree atrio-
ventricular block (AVB). Initial laboratory tests indicated
a number of abnormal values: WBC 11,000/μL (H), neu-
trophils 75.2% (H), lymphocytes 19.7% (L), D-dimer
0.55 μg/mL (H), glucose 222 mg/dL (H), BUN 34 mg/dL
(H). The following laboratory values were in the normal
range: platelets 312 × 103/μL, prothrombin time 12.9 s
and fibrinogen 305 mg/dL.
Two hours post-envenomation the patient developed
moderate swelling in his left calf and leg, tachycardia,
nausea and diaphoresis. At that time, he was started on an
initial dose of four vials of Crotalidae polyvalent immune
fab (ovine) infused over one hour.
The patient was subsequently transferred to the ICU for
monitoring, however an ECG taken three hours post-
envenomation revealed new-onset AF (Fig. 1). Cardiology
team was consulted and an amiodarone drip was started.
The patient successfully converted to normal sinus
rhythm approximately six hours after he was found to be
in AF (Fig. 2). A first-degree AVB was still present at that
time. A transthoracic echocardiogram was ordered by car-
diology and revealed mild concentric left ventricular
hypertrophy with normal systolic function and an ejection
fraction of 72%. The patient denied use of any stimulants
or sympathomimetic agents, as well as any family history
of heart disease. TSH levels were within normal limits.
The patient’s blood sugar was markedly elevated during
the first 24 h of hospitalization, and his insulin regimen
was adjusted accordingly. No further antivenom was given
as his swelling and laboratory tests were well controlled.
Coagulation studies were monitored, and the patient
continued to be stable for the rest of his hospitalization.
Fig. 1 Electrocardiogram obtained three hours post pit viper envenomation
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His laboratory studies prior to discharge were stable. He
was discharged the following day with ecchymosis around
the ankle and wound site and instructions to have his
blood work repeated at an outside laboratory.
Discussion
In 2014, over 3,000 Crotalinae envenomations were
reported to the American Association of Poison Control
Centers’ National Poison Data System. Of those envenoma-
tions, over 750 were attributed to rattlesnakes [17]. Accord-
ing to one Indian study assessing cardiac complications of
snakebite, it is estimated that up to 25% of viper family
envenomations result in cardiotoxicity [10].
Cardiovascular manifestations of snakebite, particularly of
the Viperidae family variety, are diverse. Reports of myocar-
dial infarction and cardiac tamponade have been described
in the literature, and ECG abnormalities such as T-wave
inversion and QT prolongation have been seen in several
cases [4–10, 18]. Arrhythmia is a rare complication of
snakebite and has been described infrequently; reported
arrhythmias following viper envenomation include ven-
tricular tachycardia, torsades de pointes, second-degree
AVB, and sinus arrest [9, 11–13]. In reports nonspecific to
Crotalidae or Viperidae envenomation, cases of first-degree
AVB, bundle branch block, atrial arrhythmias, complete
heart block, sinus bradycardia or tachycardia, and various
sinus arrhythmias have also been described [10, 14, 15]. To
our knowledge only one case of confirmed reversible AF fol-
lowing snakebite exists in the literature, however the species
of snake was unknown [16]. The exact mechanism respon-
sible for snakebite-induced arrhythmia remains unclear.
Several theoretical factors may have contributed to the
development of paroxysmal AF in our patient. Given his car-
diovascular risk factors, a predisposition towards arrhythmia
likely existed prior to envenomation. Advanced age, hyperlip-
idemia, long-standing type 1 diabetes mellitus and hyperten-
sion are established extracardiac predictors of AF [19]. Mild
left ventricular hypertrophy, seen on this patient’s transtho-
racic echocardiogram and likely secondary to his underlying
hypertension, is also associated with an increased risk [20].
Potential atrial electrical abnormalities may represent
another mechanism behind this patient’s development of
AF. In a 2014 retrospective study by Uhm et al. [21], first-
degree AVB was found to be an independent risk factor
(hazard ratio 2.33) for development of AF. Autonomic
nervous system activation and subsequent adrenergic
stimulation following envenomation also could have trig-
gered AF. Through several proposed electrophysiological
mechanisms in the atrium, catecholamines have been
shown to affect AF initiation and/or maintenance [22].
Fig. 2 Rhythm strips showing conversion from atrial fibrillation to normal sinus rhythm
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Additionally, arrhythmia precipitated by direct toxicity
to Crotalidae venom must be considered. Snake venom is
believed to have a potential toxic effect on the myocar-
dium, and may modify electrophysiological properties of
the cardiac cell membrane [4, 5, 11]. This could poten-
tially alter cardiac impulse generation and/or conduction;
however, a mechanism remains to be determined.
Conclusion
This report describes the case of a 73-year-old man who
developed reversible atrial fibrillation following Crotali-
nae envenomation. Although this is a rare presentation
of snakebite, in patients with pertinent risk factors for
developing AF, physicians should be aware of the poten-
tial for this arrhythmia. Direct toxic effects of venom or
structural and electrophysiological abnormalities may
predispose snakebite patients to arrhythmia, warranting
extended and attentive cardiac monitoring.
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